122 related articles for article (PubMed ID: 6670059)
1. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
Subst Alcohol Actions Misuse; 1983; 4(5):369-74. PubMed ID: 6670059
[TBL] [Abstract][Full Text] [Related]
2. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
NIDA Res Monogr; 1984 Mar; 49():262-8. PubMed ID: 6434970
[TBL] [Abstract][Full Text] [Related]
3. Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations.
Tennant F; Shannon J
J Addict Dis; 1995; 14(1):67-74. PubMed ID: 7632748
[TBL] [Abstract][Full Text] [Related]
4. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
Laqueille X; Launay C; Dervaux A; Kanit M
Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407
[TBL] [Abstract][Full Text] [Related]
5. [Plasma levomethadone level and concomitant use of sedatives in a methadone test program].
Staak M; Käferstein H; Schumacher B; Sticht G; Iffland R
Blutalkohol; 1993 Jul; 30(4):232-9. PubMed ID: 8373561
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
[TBL] [Abstract][Full Text] [Related]
7. Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment.
Pérez de los Cobos J; Siñol N; Trujols J; del Río E; Bañuls E; Luquero E; Menoyo A; Queraltó JM; Baiget M; Alvarez E
Drug Alcohol Depend; 2007 Jul; 89(2-3):190-4. PubMed ID: 17234366
[TBL] [Abstract][Full Text] [Related]
8. Altered methadone pharmacokinetics in pregnancy: implications for dosing.
Swift RM; Dudley M; DePetrillo P; Camara P; Griffiths W
J Subst Abuse; 1989; 1(4):453-60. PubMed ID: 2485290
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of methadone in maintenance clients who persist in illicit drug use.
Bell J; Bowron P; Lewis J; Batey R
Br J Addict; 1990 Dec; 85(12):1599-602. PubMed ID: 1981155
[TBL] [Abstract][Full Text] [Related]
10. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.
Peles E; Bodner G; Kreek MJ; Rados V; Adelson M
Addiction; 2007 Feb; 102(2):289-300. PubMed ID: 17222284
[TBL] [Abstract][Full Text] [Related]
11. Psychoeducational group approach: HIV risk reduction in drug users.
Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of interim methadone maintenance.
Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
[TBL] [Abstract][Full Text] [Related]
13. Non-prescribed drug use during methadone treatment by clinic- and community-based patients.
Wolff K; Hay AW; Vail A; Harrison K; Raistrick D
Addiction; 1996 Nov; 91(11):1699-704. PubMed ID: 8972927
[TBL] [Abstract][Full Text] [Related]
14. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
15. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
Bloor M; McIntosh J; McKeganey N; Robertson M
Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
[TBL] [Abstract][Full Text] [Related]
16. Pain perception of intravenous heroin users on maintenance therapy with levomethadone.
Schall U; Katta T; Pries E; Klöppel A; Gastpar M
Pharmacopsychiatry; 1996 Sep; 29(5):176-9. PubMed ID: 8895942
[TBL] [Abstract][Full Text] [Related]
17. Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting.
Kell MJ
J Addict Dis; 1994; 13(1):5-26. PubMed ID: 8018740
[TBL] [Abstract][Full Text] [Related]
18. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
[TBL] [Abstract][Full Text] [Related]
19. Methadone plasma levels in maintenance patients: the effect of dose omission.
Verebely K; Kutt H
Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):373-86. PubMed ID: 1153882
[TBL] [Abstract][Full Text] [Related]
20. Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.
Langleben DD; Ruparel K; Elman I; Busch-Winokur S; Pratiwadi R; Loughead J; O'Brien CP; Childress AR
Am J Psychiatry; 2008 Mar; 165(3):390-4. PubMed ID: 18056224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
